Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Cognitive disorders have frequently been described in the field of antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). Nevertheless, the relationship between those disorders and antiphospholipid antibodies (aPL) remains unclear and seems to involve various mechanisms. Overlap with systemic lupus erythematosus, the small sample size of studies, and discrepancies in antiphospholipid antibodies and cognitive impairment determinations complicate analyses of the literature data. In this paper, we summarize current knowledge on epidemiologic, clinical data, imaging findings and treatment of cognitive dysfunction associated with aPL. We separately analyzed data...
The antiphospholipid syndrome (APS) defines the clinical association between antiphospholipid antibo...
AbstractNeuropsychiatric systemic lupus erythematosus (NPSLE) is one of the most difficult manifesta...
During the past decade, the antiphospholipid antibody (aPL) syndrome has been delineated as a distin...
Objective The aim of this study was to compare the cognitive function of antiphospholipid antibody (...
Background Antiphospholipid syndrome (APS) is a multisystem disorder characterized by arterial and ...
OBJECTIVES: Cognitive dysfunction is common in patients with antiphospholipid antibodies (aPL) (incl...
Antiphospholipid antibodies (aPL) are well-known risk factors for venous and arterial thrombosis, bu...
Introduction: Systemic lupus erythematosus (SLE) is characterized by frequent neuropsychiatric invol...
Objective: To examine the relationship between neuropsychological impairment and antipho-spholipid a...
Antiphospholipid antibodies (aPL) have been associated with a variety of neurological disorders, mos...
role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupus er...
The role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupu...
To determine if cognitive dysfunction in patients with systemic lupus erythematosus (SLE) derives fr...
Although antiphospholipid syndrome (APS) is a multisystem prothrombotic condition, its inflammatory ...
Abstract A growing body of evidence indicates that systemic lupus erythematosus (SLE) is associated ...
The antiphospholipid syndrome (APS) defines the clinical association between antiphospholipid antibo...
AbstractNeuropsychiatric systemic lupus erythematosus (NPSLE) is one of the most difficult manifesta...
During the past decade, the antiphospholipid antibody (aPL) syndrome has been delineated as a distin...
Objective The aim of this study was to compare the cognitive function of antiphospholipid antibody (...
Background Antiphospholipid syndrome (APS) is a multisystem disorder characterized by arterial and ...
OBJECTIVES: Cognitive dysfunction is common in patients with antiphospholipid antibodies (aPL) (incl...
Antiphospholipid antibodies (aPL) are well-known risk factors for venous and arterial thrombosis, bu...
Introduction: Systemic lupus erythematosus (SLE) is characterized by frequent neuropsychiatric invol...
Objective: To examine the relationship between neuropsychological impairment and antipho-spholipid a...
Antiphospholipid antibodies (aPL) have been associated with a variety of neurological disorders, mos...
role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupus er...
The role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupu...
To determine if cognitive dysfunction in patients with systemic lupus erythematosus (SLE) derives fr...
Although antiphospholipid syndrome (APS) is a multisystem prothrombotic condition, its inflammatory ...
Abstract A growing body of evidence indicates that systemic lupus erythematosus (SLE) is associated ...
The antiphospholipid syndrome (APS) defines the clinical association between antiphospholipid antibo...
AbstractNeuropsychiatric systemic lupus erythematosus (NPSLE) is one of the most difficult manifesta...
During the past decade, the antiphospholipid antibody (aPL) syndrome has been delineated as a distin...